DENTSPLY SIRONA Inc
Dentsply Sirona Inc (XRAY) has a market cap of $2.33B and a current price of $11.99, reflecting a 4.08% increase today, yet the company faces significant challenges with a year-over-year revenue decline of 2.98% and a troubling return on equity (ROE) of -35.24%. Despite a dividend yield of 5.50%, the stock's performance is negatively impacted by a recent earnings miss in Q4 2025, where EPS came in at $0.27 compared to expectations of $0.2836. With a price-to-sales ratio of 0.65, the stock appears undervalued, but the financial metrics suggest deeper operational issues that could hinder recovery.
Given the negative financial indicators and recent earnings misses, I recommend avoiding Dentsply Sirona stock at this time.
Dentsply Sirona: Another Episode Of An Anticipated Recovery
2026-04-09
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now
2026-04-01
Does Revenue And Margin Pressure Undermine XRAY’s Efficiency-Driven Turnaround Story?
2026-04-03
3 Reasons to Avoid XRAY and 1 Stock to Buy Instead
2026-03-30